BioAge Labs, Inc.
BIOA
$10.60
$0.171.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.27% | 14.22% | -28.62% | 6.46% | -66.79% |
| Total Depreciation and Amortization | 11.11% | -8.70% | 40.82% | -15.52% | 56.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.59% | 204.49% | -52.33% | -14.20% | 8.59% |
| Change in Net Operating Assets | 147.03% | -60.44% | -404.48% | 168.66% | 76.27% |
| Cash from Operations | 19.90% | 14.88% | -76.08% | 19.66% | -15.01% |
| Capital Expenditure | -1,161.54% | 76.79% | -409.09% | 86.16% | 62.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -251.37% | -226.40% | -211.30% | 183.08% | 80.04% |
| Cash from Investing | -251.88% | -224.04% | -212.36% | 182.10% | 79.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 66.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -86.25% | 605.25% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.44% | -126.69% | -709.09% | -- | -- |
| Cash from Financing | -87.09% | 672.59% | 1,137.11% | -2.93% | 0.00% |
| Foreign Exchange rate Adjustments | 81.48% | -42.11% | -90.00% | 78.26% | -283.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -417.29% | 298.20% | -460.96% | 87.20% | 61.64% |